RE:AESPGood that ASEP flaunts their product to the investing community to garner a MC that is more than 1/3 of Spectral's with just a small piece of the diagnostic side - with no proposed treatment plan (other than maybe a modified cocktail of antibiotics)
The EAA has been a personalized diagnostic tool (sort of an AI tool) that has been around for 20+ years.
Higher levels of Endotoxins puts patient more at risk. EAA detects a problem that may be more severe, within 15 min.
But the good news is that this product puts more attention on Severe Sepsis. Asep can't fix the problem so while it may be another companion diagnostic, they will still need PMX (in many cases e.g. gram-negative >.x) in order to treat/cure the patient.
Also acknowledged is the problem of Antibiotic resistent bugs which is a growing problem that will lead to more deaths (again unless there are earlier treatments, and other treatments are approved besides antibiotics)
MM (lay-person perspective)